Tags
Segreteria Organizzativa e Coordinamento Generale
Pierrel Research Italy
Via Alberto Falck, 15
20099 Sesto San Giovanni (MI)
Tel: +39 02 24134.260
Fax: +39 02 24862994
e-mail: info@spread.it
Con il contributo di
17 Ictus pediatrico e giovanile – Ictus di origine rara
Voce bibliografica LynchJK,2005 capitolo 17
17.LynchJK,2005 - Lynch JK, Pavlakis S, De Veber G.
Lynch JK, Pavlakis S, De Veber G. Treatment and prevention of cerebrovascular disorders in children. Curr Treat Options Neurol 2005; 7: 469-480.
Voce bibliografica LynchJK,2002 capitolo 17
17.LynchJK,2002 - Lynch JK, Hirtz DG, DeVeber G, Nelson KB.
Lynch JK, Hirtz DG, deVeber G, Nelson KB. Report of the National Institute of Neurological Disorders and Stroke workshop on perinatal and childhood stroke. Pediatrics 2002; 109: 116-123.
Voce bibliografica KittnerSJ,1996 capitolo 17
17.KittnerSJ,1996 - Kittner SJ, Adams RJ.
Kittner SJ, Adams RJ. Stroke in children and young adults. Curr Opin Neurol 1996; 9: 53-56.
Voce bibliografica GiroudM,1995 capitolo 17
17.GiroudM,1995 - Giroud M, Lemesle M, Gouyon JB, Nivelon JL, Milan C, Dumas R.
Giroud M, Lemesle M, Gouyon JB, Nivelon JL, Milan C, Dumas R. Cerebrovascular disease in children under 16 years of age in the city of Dijon, France: a study of incidence and clinical features from 1985 to 1993. J Clin Epidemiol 1995; 48: 1343-1348.
Voce bibliografica deVeberG,2000 capitolo 17
17.deVeberG,2000 - deVeber G.
deVeber G. Canadian Pediatric Ischemic Stroke Registry. Paediatr Child Health 2000; A17 [Abstract].
Voce bibliografica MariniC,2001 capitolo 17
17.MariniC,2001 - Marini C, Totaro R, De Santis F, Ciancarelli I, Baldassarre M, Carolei A.
Marini C, Totaro R, De Santis F, Ciancarelli I, Baldassarre M, Carolei A. Stroke in young adults in the community-based L’Aquila registry: incidence and prognosis. Stroke 2001; 32: 52-56.
Voce bibliografica RadhakrishnanK,1986 capitolo 17
17.RadhakrishnanK,1986 - Radhakrishnan K, Ashok PP, Sridharan R, Mousa ME.
Radhakrishnan K, Ashok PP, Sridharan R, Mousa ME. Stroke in the young: incidence and pattern in Benghazi, Libya. Acta Neurol Scand 1986; 73: 434-438.
Voce bibliografica AndersonCS,1993 capitolo 17
17.AndersonCS,1993 - Anderson CS, Jamrozik KD, Burvill PW, Chakera TM, Johnson GA, Stewart-Wynne EG.
Anderson CS, Jamrozik KD, Burvill PW, Chakera TM, Johnson GA, Stewart-Wynne EG. Ascertaining the true incidence of stroke: experience from the Perth Community Stroke Study, 1989-1990. Med J Aust 1993; 158: 80-84.
Voce bibliografica RosmanKD,1986 capitolo 17
17.RosmanKD,1986 - Rosman KD.
Rosman KD. The epidemiology of stroke in an urban black population. Stroke 1986; 17: 667-669.
Voce bibliografica Rozenthul-SorokinN,1996 capitolo 17
17.Rozenthul-SorokinN,1996 - Rozenthul-Sorokin N, Ronen R, Tamir A, Geva H, Eldar R.
Rozenthul-Sorokin N, Ronen R, Tamir A, Geva H, Eldar R. Stroke in the young in Israel. Incidence and outcomes. Stroke 1996; 27: 838-841.
Voce bibliografica JerntorpP,1992 capitolo 17
17.JerntorpP,1992 - Jerntorp P, Berglund G.
Jerntorp P, Berglund G. Stroke registry in Malmö, Sweden. Stroke 1992; 23: 357-361.
Voce bibliografica JacobsBS,2002 capitolo 17
17.JacobsBS,2002 - Jacobs BS, Boden-Albala B, Lin IF, Sacco RL.
Jacobs BS, Boden-Albala B, Lin IF, Sacco RL. Stroke in the young in the northern Manhattan stroke study. Stroke 2002; 33: 2789-2793.
Voce bibliografica BamfordJ,1990 capitolo 17
17.BamfordJ,1990 - Bamford J, Sandercock P, Dennis M, Burn J, Warlow C.
Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project--1981-86. 2. Incidence, case fatality rates and overall outcome at one year of cerebral infarction, primary intracerebral and subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 1990; 53: 16-22.
Voce bibliografica CzlonkowskaA,1994 capitolo 17
17.CzlonkowskaA,1994 - Czlonkowska A, Ryglewicz D, Weissbein T, Baranska-Gieruszczak M, Hier DB.
Czlonkowska A, Ryglewicz D, Weissbein T, Baranska-Gieruszczak M, Hier DB. A prospective community-based study of stroke in Warsaw, Poland. Stroke 1994; 25: 547-551.
Voce bibliografica MariniC,1999 capitolo 17
17.MariniC,1999 - Marini C, Totaro R, Carolei A.
Marini C, Totaro R, Carolei A, for the National Research Council Study Group on Stroke in the Young. Long-term prognosis of cerebral ischemia in young adults. Stroke 1999; 30: 2320-2325.
Voce bibliografica NedeltchevK,2005 capitolo 17
17.NedeltchevK,2005 - Nedeltchev K, der Maur TA, Georgiadis D, Arnold M, Caso V, Mattle HP, Schroth G, Remonda L, Sturzenegger M, Fischer U, Baumgartner RW.
Nedeltchev K, der Maur TA, Georgiadis D, Arnold M, Caso V, Mattle HP, Schroth G, Remonda L, Sturzenegger M, Fischer U, Baumgartner RW. Ischaemic stroke in young adults: predictors of outcome and recurrence. J Neurol Neurosurg Psychiatry 2005; 76: 191-195.
Voce bibliografica KappelleLJ,1994 capitolo 17
17.KappelleLJ,1994 - Kappelle LJ, Adams HP Jr, Heffner ML, Torner JC, Gomez F, Biller J.
Kappelle LJ, Adams, HP, Heffner ML, Torner JC, Gomez F, Biller J. Prognosis of young adults with ischemic stroke: a long-term follow-up study assessing recurrent vascular events and functional outcome in the Iowa Registry of Stroke in Young Adults. Stroke 1994; 25: 1360-1365.
Voce bibliografica AriasE,2003 capitolo 17
17.AriasE,2003 - Arias E, Anderson RN, Kung HC, Murphy SL, Kochanek KD.
Arias E, Anderson RN, Kung HC, Murphy SL, Kochanek KD. Deaths: final data for 2001. Natl Vital Stat Rep 2003; 52: 1-115.
Voce bibliografica WraigeE,2005 capitolo 17
17.WraigeE,2005 - Wraige E, Pohl KR, Ganesan V.
Wraige E, Pohl KR, Ganesan V. A proposed classification for subtypes of arterial ischaemic stroke in children. Dev Med Child Neurol 2005; 47: 252-256.
Voce bibliografica Al-SulaimanA,1999 capitolo 17
17.Al-SulaimanA,1999 - Al-Sulaiman A, Bademosi O, Ismail H, Magboll G.
Al-Sulaiman A, Bademosi O, Ismail H, Magboll G. Stroke in Saudi children. J Child Neurol 1999; 14: 295-298.
Voce bibliografica LeysD,2003 capitolo 17
17.LeysD,2003 - Leys D.
Leys D. Ischemic strokes in young adults Rev Med Interne 2003; 24: 585-593.
Voce bibliografica KirkhamFJ,1999 capitolo 17
17.KirkhamFJ,1999 - Kirkham FJ.
Kirkham FJ. Stroke in childhood. Arch Dis Child 1999; 81: 85-89.
Voce bibliografica RielaAR,1993 capitolo 17
17.RielaAR,1993 - Riela AR, Roach ES.
Riela AR, Roach ES. Etiology of stroke in children. J Child Neurol 1993; 8: 201-220.
Voce bibliografica ZimmermanRA,1998 capitolo 17
17.ZimmermanRA,1998 - Zimmerman RA, Haselgrove JC, Wang Z, Hunter JV, Morriss MC, Hoydu A, Bilaniuk LT.
Zimmerman RA, Haselgrove JC, Wang Z, Hunter JV, Morriss MC, Hoydu A, Bilaniuk LT. Advances in pediatric neuroimaging. Brain Dev 1998; 20: 275-289.
Voce bibliografica GadianDG,2000 capitolo 17
17.GadianDG,2000 - Gadian DG, Calamante F, Kirkham FJ, Bynevelt M, Johnson CL, Porter DA, Chong WK, Prengler M, Connelly A.
Gadian DG, Calamante F, Kirkham FJ, Bynevelt M, Johnson CL, Porter DA, Chong WK, Prengler M, Connelly A. Diffusion and perfusion magnetic resonance imaging in childhood stroke. J Child Neurol 2000; 15: 279-283.
Voce bibliografica LynchJK,2004 capitolo 17
17.LynchJK,2004 - Lynch JK.
Lynch JK. Cerebrovascular disorders in children. Curr Neurol Neurosci Rep 2004; 4: 129-138.
Voce bibliografica TheRoyalCollege,2006 capitolo 17
17.TheRoyalCollege,2006 - The Royal College of Physicians, Paediatric Stroke Working Group.
The Royal College of Physicians, Paediatric Stroke Working Group. Stroke in childhood-Clinical guidelines for diagnosis,management and rehabilitation. http://www rcplondon ac uk/pubs/books/childstroke/ 2004;Available at: URL: http://www.rcplondon.ac.uk/pubs/books/childstroke/. AccessedJune 15, 2006.
Voce bibliografica WirrellEC,2001 capitolo 17
17.WirrellEC,2001 - Wirrell EC, Armstrong EA, Osman LD, Yager JY.
Wirrell EC, Armstrong EA, Osman LD, Yager JY. Prolonged seizures exacerbate perinatal hypoxic-ischemic brain damage. Pediatr Res 2001; 50: 445-454.
Voce bibliografica MonagleP,2004 capitolo 17
17.MonagleP,2004 - Monagle P, Chan A, Massicotte P, Chalmers E, Michelson AD.
Monagle P, Chan A, Massicotte P, Chalmers E, Michelson AD. Antithrombotic therapy in children: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126 (3 Suppl): 645S-687S.
Voce bibliografica ThirumalaiSS,2000 capitolo 17
17.ThirumalaiSS,2000 - Thirumalai SS, Shubin RA.
Thirumalai SS, Shubin RA. Successful treatment for stroke in a child using recombinant tissue plasminogen activator. J Child Neurol 2000; 15: 558.
Voce bibliografica GruberA,2000 capitolo 17
17.GruberA,2000 - Gruber A, Nasel C, Lang W, Kitzmüller E, Bavinzski G, Czech T.
Gruber A, Nasel C, Lang W, Kitzmuller E, Bavinzski G, Czech T. Intra-arterial thrombolysis for the treatment of perioperative childhood cardioembolic stroke. Neurology 2000; 54: 1684-1686.
Voce bibliografica NoserEA,2001 capitolo 17
17.NoserEA,2001 - Noser EA, Felberg RA, Alexandrov AV.
Noser EA, Felberg RA, Alexandrov AV. Thrombolytic therapy in an adolescent ischemic stroke. J Child Neurol 2001; 16: 286-288.
Voce bibliografica GolombMR-RafayM,2003 capitolo 17
17.GolombMR-RafayM,2003 - Golomb MR, Rafay M, Armstrong D, Massicotte P, Curtis R, Hune S, deVeber GA.
Golomb MR, Rafay M, Armstrong D, Massicotte P, Curtis R, Hune S, deVeber GA. Intra-arterial tissue plasminogen activator for thrombosis complicating cerebral angiography in a 17-year-old girl. J Child Neurol 2003; 18: 420-423.
Voce bibliografica KirtonA,2003 capitolo 17
17.KirtonA,2003 - Kirton A, Wong JH, Mah J, Ross BC, Kennedy J, Bell K, Hill MD.
Kirton A, Wong JH, Mah J, Ross BC, Kennedy J, Bell K, Hill MD. Successful endovascular therapy for acute basilar thrombosis in an adolescent. Pediatrics 2003; 112 (3 Pt 1): e248-e251.
Voce bibliografica BourekasEC,2005 capitolo 17
17.BourekasEC,2005 - Bourekas EC, Slivka AP, Casavant MJ.
Bourekas EC, Slivka AP, Casavant MJ. Intra-arterial thrombolysis of a distal internal carotid artery occlusion in an adolescent. Neurocrit Care 2005; 2: 179-182.
Voce bibliografica WangM,2003 capitolo 17
17.WangM,2003 - Wang M, Hays T, Balasa V, Bagatell R, Gruppo R, Grabowski EF, Valentino LA, Tsao-Wu G, Manco-Johnson MJ; Pediatric Coagulation Consortium.
Wang M, Hays T, Balasa V, Bagatell R, Gruppo R, Grabowski EF, Valentino LA, Tsao-Wu G, Manco-Johnson MJ. Low-dose tissue plasminogen activator thrombolysis in children. J Pediatr Hematol Oncol 2003; 25: 379-386.
Voce bibliografica ZenzW,1997 capitolo 17
17.ZenzW,1997 - Zenz W, Arlt F, Sodia S, Berghold A.
Zenz W, Arlt F, Sodia S, Berghold A. Intracerebral hemorrhage during fibrinolytic therapy in children: a review of the literature of the last thirty years. Semin Thromb Hemost 1997; 23: 321-332.
Voce bibliografica ChabrierS,2000 capitolo 17
17.ChabrierS,2000 - Chabrier S, Husson B, Lasjaunias P, Landrieu P, Tardieu M.
Chabrier S, Husson B, Lasjaunias P, Landrieu P, Tardieu M. Stroke in childhood: outcome and recurrence risk by mechanism in 59 patients. J Child Neurol 2000; 15: 290-294.
Voce bibliografica LanthierS,2000 capitolo 17
17.LanthierS,2000 - Lanthier S, Carmant L, David M, Larbrisseau A, de Veber G.
Lanthier S, Carmant L, David M, Larbrisseau A, de Veber G. Stroke in children: the coexistence of multiple risk factors predicts poor outcome. Neurology 2000; 54: 371-378.
Voce bibliografica PerlmanJM,1994 capitolo 17
17.PerlmanJM,1994 - Perlman JM, Rollins NK, Evans D.
Perlman JM, Rollins NK, Evans D. Neonatal stroke: clinical characteristics and cerebral blood flow velocity measurements. Pediatr Neurol 1994; 11: 281-284.
Voce bibliografica SchoenbergBS,1978 capitolo 17
17.SchoenbergBS,1978 - Schoenberg BS, Mellinger JF, Schoenberg DG.
Schoenberg BS, Mellinger JF, Shoenberg DG. Cerebrovasular disease in infants and children: a study of incidence, clinical features and survival. Neurology 1978; 28: 763-768.
Voce bibliografica KleindorferD,2006 capitolo 17
17.KleindorferD,2006 - Kleindorfer D, Khoury J, Kissela B, Alwell K, Woo D, Miller R, Schneider A, Moomaw C, Broderick JP.
Kliendorfer D, Khoury J, Kissela B, Alwell K, Woo D, Miller Rosemary, Schneider A, Moomaw C, Broderick JP. Temporal trans in the incidence and case fatality of stroke in children and adolescents. J Child Neurol 2006; 21: 415-419.
Voce bibliografica SilaA,2006 capitolo 17
17.SilaA,2006 - Sila CA.
Sila A. Heart disease and stroke. Curr Neurol Nurosci Rep 2006; 6: 23-27.
Voce bibliografica LanskaMJ,1991 capitolo 17
17.LanskaMJ,1991 - Lanska MJ, Lanska DJ, Horwitz SJ, Aram DM.
Lanska MJ, Lanska DJ, Horwitz SJ, Aram DM. Presentation, clinical course, and outcome of childhood stroke. Pediatr Neurol 1991; 7: 333-341.
Voce bibliografica GanesanV,2003 capitolo 17
17.GanesanV,2003 - Ganesan V, Prengler M, McShane MA, Wade AM, Kirkham FJ.
Ganesan V, Prengler M, McShane MA, Wade AM, Kirkham FJ. Investigation of risk factors in children with arterial ischemic stroke. Ann Neurol 2003; 53: 167-173.
Voce bibliografica AndrewM,2000 capitolo 17
17.AndrewM,2000 - Andrew M, Monagle PT, Brooker LA.
Andrew M, Monagle PT, Brooker LA. Thromboembolic complications during infancy and childhood. Hamilton, Ont; Lewiston, N.Y.: B.C. Decker; 2000.
Voce bibliografica OverellJR,2000 capitolo 17
17.OverellJR,2000 - Overell JR, Bone I, Lees KR.
Overell JR, Bone I, Lees KR. Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology 2000; 55: 1172-1179.
Voce bibliografica AvierinosJF,2003 capitolo 17
17.AvierinosJF,2003 - Avierinos JF, Brown RD, Foley DA, Nkomo V, Petty GW, Scott C, Enriquez-Sarano M.
Avierinos JF, Brown RD, Foley DA, Nkomo V, Petty GW, Scott C, Enriquez-Sarano M. Cerebral ischemic events after diagnosis of mitral valve prolapse: a community-based study of incidence and predictive factors. Stroke.2003; 34: 1339-1344.
Voce bibliografica PinedeL,2001 capitolo 17
17.PinedeL,2001 - Pinede L, Duhaut P, Loire R.
Pinede L, Duhaut P, Loire R. Clinical presentation of left atrial cardiac myxoma. A series of 112 consecutive cases. Medicine (Baltimore) 2001; 80: 159-172.
Voce bibliografica 50 capitolo 17
17.50 - Ricci R, Castorina M, Di Lillo M, Antuzzi D, Frustaci A, Parini R, Menni F, Furlan F, Burlina A, Burlina A, Catuogno S, Gabrielli O, Burattini I, Borsini W, Buchner S, Ferriozzi S, Spisni C, De Vito R, Di Rocco M, Aricò M, Pistone G, Bongiorno AM, Morrone A, Cavicchi C, Zammarchi E.
Ricci R, Castorina M, Di Lillo M, Antuzzi D, Frustaci A, Parini R, Menni F, Furlan F, Burlina A, Burlina A, Catuogno S, Gabrielli O, Burattini I, Borsini W, Büchner S, Ferriozzi S, Spisni C, De Vito R, Di Rocco M, Aricò M, Pistone G, Bongiorno AM, Morrone A, Cavicchi C, Zammarchi E. Primo studio epidemiologico e collaborativo italiano sulla malattia di Fabry. Ann Ital Med Int 2004; 19: 269-275.
Voce bibliografica RolfsA,2005 capitolo 17
17.RolfsA,2005 - Rolfs A, Böttcher T, Zschiesche M, Morris P, Winchester B, Bauer P, Walter U, Mix E, Löhr M, Harzer K, Strauss U, Pahnke J, Grossmann A, Benecke R.
Rolfs A, Böttcher T, Zschiesche M, Morris P, Winchester B, Bauer P, Walter U, Mix E, Löhr M, Harzer K, Strauss U, Pahnke J, Grossmann A, Benecke R. Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study. Lancet 2005; 366: 1794-1796.
Voce bibliografica 52 capitolo 17
17.52 - Mehta A, Ricci R, Widmer U, Dehout F, Garcia de Lorenzo A, Kampmann C, Linhart A, Sunder-Plassmann G, Ries M, Beck M.
Mehta A, Ricci R, Widmer U, Dehout F, Gracia de Lorenzo A, Kampmann C, Linhart A, Sunder-Plassmann G, Ries M, Beck M. Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry outcome survey. Eur J Clin Invest 2004; 34: 236-242.
Voce bibliografica RiesM,2007 capitolo 17
17.RiesM,2007 - Ries M, Kim HJ, Zalewski CK, Mastroianni MA, Moore DF, Brady RO, Dambrosia JM, Schiffmann R, Brewer CC.
Ries M, Kim HJ, Zalewski CK, Mastroianni MA, Moore DF, Brady RO, Dambrosia JM, Schiffmann R, Brewer CC. Neuropathic and cerebrovascular correlates of hearing loss in Fabry disease. Brain 2007; 130: 143-150.
Voce bibliografica 54 capitolo 17
17.54 - Banikazemi M, Ullman T, Desnick RJ.
Banikazemi M, Ullman T, Desnick RJ. Gastrointestinal manifestations of Fabry disease: clinical response to enzyme replacement therapy. Mol Genet Metab 2005; 85: 255-259.
Voce bibliografica Mitsia P,1996 capitolo 17
17.Mitsia P,1996 - Mitsias P, Levine SR.
Mitsias P, Levine SR. Cerebrovascular complications of Fabry’s disease. Ann Neurol 1996; 40: 8-17.
Voce bibliografica GinsbergL,2006 capitolo 17
17.GinsbergL,2006 - Ginsberg L, Manara R, Valentine AR, Kendall B, Burlina AP.
Ginsberg L, Manara R, Valentine AR, Kendall B, Burlina AP. Magnetic resonance imaging changes in Fabry disease. Acta Paediatrica 2006; Suppl 451: 57-62.
Voce bibliografica DesnickRJ,2001 capitolo 17
17.DesnickRJ,2001 - Desnick RJ, Ioannou YA, Eng CM.
Desnick RJ, Ioannou YA, Eng CM. a-Galactosidase A deficiency: Fabry disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D eds. The Metabolic and Molecular Bases of Inherited Disease, Vol. III, 8th ed. New York; McGraw-Hill 2001: p. 3733-3774.
Voce bibliografica ShabbeerJ,2002 capitolo 17
17.ShabbeerJ,2002 - Shabbeer J, Yasuda M, Luca E, Desnick RJ.
Shabbeer J, Yasuda M, Luca E, Desnick RJ. Fabry disease: 45 novel mutations in the a-galactosidase A gene causing the classical phenotype. Mol Genet Metab 2002; 76: 23-30.
Voce bibliografica SodiA,2006 capitolo 17
17.SodiA,2006 - Sodi A, Ioannidis A, Pitz S.
Sodi A, Ioannidis A, Pitz S. Ophthalmological manifestations of Fabry disease. In: Mehta A, Beck M, Sunder-Plassmann eds. Fabry Disease: Perspectives from 5 Years of FOS. Oxford 2006: p. 249-261.
Voce bibliografica SchiffmannR,2001 capitolo 17
17.SchiffmannR,2001 - Schiffmann R, Kopp JB, Austin HA 3rd, Sabnis S, Moore DF, Weibel T, Balow JE, Brady RO.
Schiffmann R, Kopp JB, Austin HA, Sabnis S, Moore DF, Weibel T, Balow JE, Brady RO. Enzyme replacement therapy in Fabry disease. A randomized controlled trial. JAMA 2001; 285: 2743-2749.
Voce bibliografica EngCM,2001 capitolo 17
17.EngCM,2001 - Eng CM, Guffon N, Wilcox WR, Germain DP, Lee P, Waldek S, Caplan L, Linthorst GE, Desnick RJ; International Collaborative Fabry Disease Study Group.
Eng CM, Guffon N, Wilcox WR, Germani DP, Lee P, Waldek S, Caplan L, Linthorst GE, Desnick RJ. Safety and efficacy of recombinant human a-galactosidase A replacement therapy in Fabry’s disease. N Engl J Med 2001; 345: 9-16.
Voce bibliografica 62 capitolo 17
17.62 - Hajioff D, Enever Y, Quiney R, Zuckerman J, Mackermot K, Mehta A.
Hajioff D, Enever Y, Quiney R, Zuckerman J, MacDermot K, Mehta A. Hearing loss in Fabry disease: the effect of agalsidase alfa replacement. J Inherit Metab Dis 2003; 26: 787-794.
Voce bibliografica AndriaG,2006 capitolo 17
17.AndriaG,2006 - Andria G, Fowler B, Sebastio G.
Andria G, Fowler B, Sebastio G. Disorders of sulfur amino acid metabolism. In: Fernandes J, Saudabray J.M, van den Berghe G, Walter JW eds. Inborn Metabolic Diseases. Diagnosis and Treatment, 4th ed. Heidelberg 2006; Springer: p. 273-282.
Voce bibliografica YapS,2003 capitolo 17
17.YapS,2003 - Yap S.
Yap S. Classical homocystinuria: vascular risk and its prevention. J Inherit Metab Dis 2003; 26: 259-265.
Voce bibliografica CasasJP,2005 capitolo 17
17.CasasJP,2005 - Casas JP, Bautista LE, Smeeth L, Sharma P, Hingorani AD.
Casas JP, Bautista LE, Smeeth L, Sharma P, Hingorani AD. Homocysteine and stroke: evidence on a causal link from mendelian randomisation. Lancet 2005; 365: 224-232.
Voce bibliografica 66 capitolo 17
17.66 - Homocysteine Studies Collaboration.
The Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke. JAMA 2002; 288: 2015-2022.
Voce bibliografica KellyJP,2003 capitolo 17
17.KellyJP,2003 - Kelly PJ, Furie KL, Kistler JP, Barron M, Picard EH, Mandell R, Shih VE.
Kelly JP, Furie KL, Kistler JP, Barron M, Picard EH, Mandell R, Shih VE. Stroke in young patients with hyperhomocysteinemia due to cystathionine beta-synthase deficiency. Neurology 2003; 60: 275-279.
Voce bibliografica YapS,2001 capitolo 17
17.YapS,2001 - Yap S, Boers GH, Wilcken B, Wilcken DE, Brenton DP, Lee PJ, Walter JH, Howard PM, Naughten ER.
Yap S, Boers GHJ, Wilcken B, Wilcken DEL, Brenton DP, Lee PJ, Walter JH, Howard PM, Naughten ER. Vascular outcome in patients with homocystinuria due to cystathionine b-synthase deficiency treated chronically: a multicenter observational study. Arterioscl Thromb Vasc Biol 2001; 21: 2080-2085.
Voce bibliografica DeodatoF,2006 capitolo 17
17.DeodatoF,2006 - Deodato F, Boenzi S, Santorelli FM, Dionisi-Vici C.
Deodato F, Bonzi S, Santorelli FM, Dionisi-Vici C. Methylmalonic and propionic aciduria. Am J Med Genet Part C Semin Med Genet 2006; 142C: 104-112.
Voce bibliografica BurlinaAP,2001 capitolo 17
17.BurlinaAP,2001 - Burlina AP, Baracchini C, Carollo C, Burlina AB.
Burlina AP, Baracchini C, Carollo C, Burlina AB. Propionic acidaemia with basal ganglia stroke: treatment of acute extrapyramidal symptoms with L-DOPA. J Inherit Metab Dis 2001; 24: 596-598.
Voce bibliografica BurlinaAP,2003 capitolo 17
17.BurlinaAP,2003 - Burlina AP, Manara R, Calderone M, Catuogno S, Burlina AB.
Burlina AP, Manara R, Calderone M, Catuogno S, Burlina AB. Diffusion-weighted imaging in the assessment of neurological damage in patients with methylmalonic aciduria. J Inherit Metab Dis 2003; 26: 417-422.
Voce bibliografica BurlinaAP,2005 capitolo 17
17.BurlinaAP,2005 - Burlina AP. Neurological phenomena. In: de Valk HW, Barriento Martinez ZM.
Burlina AP. Neurological phenomena. In: de Valk HW, Barriento Martinez, ZM. Practical Approach to Rare metabolic Disorders In Adulthood. Utrecht; Lemma Publishers 2005: p. 39-48.
Voce bibliografica HendersonGV,1997 capitolo 17
17.HendersonGV,1997 - Henderson GV, Kittner SJ, Johns DR
Henderson GV, Kittner SJ, Johns DR. An incidence study of stroke secondary to MELAS in the young. Neurology. 1997; 48: A403. [Abstract]
Voce bibliografica HiranoM,1992 capitolo 17
17.HiranoM,1992 - Hirano M, Ricci E, Koenigsberger MR, Defendini R, Pavlakis SG, DeVivo DC, DiMauro S, Rowland LP.
Hirano M, Ricci E, Koenigsberger MR, Defendini R, Pavlakis SG, DeVivo DC, DiMauro S, Rowland LP. Melas: an original case and clinical criteria for diagnosis. Neuromuscul Disord 1992; 2: 125-135.
Voce bibliografica MontagnaP,1988 capitolo 17
17.MontagnaP,1988 - Montagna P, Gallassi R, Medori R, Govoni E, Zeviani M, Di Mauro S, Lugaresi E, Andermann F.
Montagna P, Gallassi R, Medori R, Govoni E, Zeviani M, Di Mauro S, Lugaresi E, Andermann F MELAS syndrome: characteristic migrainous and epileptic features and maternal transmission. Neurology 1988; 38: 751-754.
Voce bibliografica Martinez-FernandezE,2001 capitolo 17
17.Martinez-FernandezE,2001 - Martínez-Fernández E, Gil-Peralta A, García-Lozano R, Chinchón I, Aguilera I, Fernández-López O, Arenas J, Campos Y, Bautista J.
Martinez-Fernandez E, Gil-Peralta A, Garcia-Lozano R, Chinchon I, Aguilera I, Fernandez-Lopez O, Arenas J, Campos Y, Bautista J. Mitochondrial disease and stroke. Stroke 2001; 32: 2507-2510.
Voce bibliografica SueCM,1998 capitolo 17
17.SueCM,1998 - Sue CM, Crimmins DS, Soo YS, Pamphlett R, Presgrave CM, Kotsimbos N, Jean-Francois MJ, Byrne E, Morris JG.
Sue CM, Crimmins DS, Soo YS, Pamphlett R, Presgrave CM, Kotsimbos N, Jean-Francois MJ, Byrne E, Morris JG. Neuroradiological features of six kindreds with MELAS tRNA(Leu) A2343G point mutation: implications for pathogenesis. J Neurol Neurosurg Psychiatry 1998; 65: 233-240.
Voce bibliografica AbeK,2004 capitolo 17
17.AbeK,2004 - Abe K, Yoshimura H, Tanaka H, Fujita N, Hikita T, Sakoda S.
Abe K, Yoshimura H, Tanaka H, Fujita N, Hikita T, Sakoda S. Comparison of conventional and diffusion-weighted MRI and proton MR spectroscopy in patients with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like events. Neuroradiology 2004; 46: 113-117.
Voce bibliografica ClarkJM,1996 capitolo 17
17.ClarkJM,1996 - Clark JM, Marks MP, Adalsteinsson E, Spielman DM, Shuster D, Horoupian D, Albers GW.
Clark JM, Marks MP, Adalsteinsson E. MELAS: clinical and pathologic correlations with MRI, xenon-CT and MR spectroscopy. Neurology 1996; 46: 223-227.
Voce bibliografica MiyakisS,2006 capitolo 17
17.MiyakisS,2006 - Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, DE Groot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA.
Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, DE Groot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295-306.
Voce bibliografica 82 capitolo 17
17.82 - Alarcón-Segovia D, Sanchez-Guerrero J.
Alarcon-Segovia D, Sanchez-Guerrero J. Primary Antiphospholipid Syndrome. J Rheumatol 1989; 16: 482-488.
Voce bibliografica AshersonRA,2003 capitolo 17
17.AshersonRA,2003 - Asherson RA, Cervera R, de Groot PG, Erkan D, Boffa MC, Piette JC, Khamashta MA, Shoenfeld Y; Catastrophic Antiphospholipid Syndrome Registry Project Group.
Asherson RA, Cervera R, de Groot PG, Erkan D, Boffa MC, Piette JC, Khamashta MA, Shoenfeld Y; Catastrophic Antiphospholipid Syndrome Registry Project Group. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus 2003; 12: 530-534.
Voce bibliografica BickRL,2001 capitolo 17
17.BickRL,2001 - Bick RL.
Bick RL. Antiphospholipid thrombosis syndromes. Clin Appl Thromb Hemost 2001; 7: 241-258.
Voce bibliografica BrayRL,2002 capitolo 17
17.BrayRL,2002 - Brey RL, Chapman J, Levine SR, Ruiz-Irastorza G, Derksen RH, Khamashta M, Shoenfeld Y.
Bray RL, Chapman J, Levine SR, Ruiz-Irastorza G, Derksen RH, Khamashta M, Shoenfeld Y. Stroke and the antiphospholipid syndrome: consensus meeting Taormina 2002. Lupus 2003; 12: 508-513.
Voce bibliografica HuntJ,1994 capitolo 17
17.HuntJ,1994 - Hunt J, Krilis S.
Hunt J., Krilis S. The fifth domain of b-2 glycoprotein-1 contains a phospholipid binding site. J Immunol 1994; 152: 653-659.
Voce bibliografica HessDC,1993 capitolo 17
17.HessDC,1993 - Hess DC, Sheppard JC, Adams RJ.
Hess DC, Sheppard JC, Adams RJ. Increased immunoglobulin binding to cerebral endothelium in patients with antiphospholipid antibodies. Stroke 1993; 24: 994-999.
Voce bibliografica TheAntiphospholipid,1993 capitolo 17
17.TheAntiphospholipid,1993 - The Antiphospholipid Antibodies in Stroke Study (APASS) Group
The Antiphospholipid Antibodies in Stroke Study (APASS) Group: Clinical, radiological and pathological aspects of cerebrovascular disease associated with antiphospholipid antibodies. Stroke 1993; 24 (12 Suppl): I120-I123.
Voce bibliografica FinazziG,1996 capitolo 17
17.FinazziG,1996 - Finazzi G, Barbui B.
Finazzi G, Barbui B. Feasibility of a randomized clinical trial for the prevention of recurrent thrombosis in the antiphospholipid syndrome: the WAPS project. Provisional Steering Committee of the Warfarin in Antiphospholipid Syndrome (WAPS) Study. Ann Med Interne (Paris) 1996; 147 (Suppl 1): 38-41.
Voce bibliografica ToschiV,1998 capitolo 17
17.ToschiV,1998 - Toschi V, Motta A, Castelli C, Paracchini ML, Zerbi D, Gibelli A.
Toschi V, Motta A, Castelli C, Paracchini ML, Zerbi D, Gibelli A. High prevalence of antiphosphatidylinositol antibodies in young patients with cerebral ischemia of undetermined cause. Stroke 1998; 29: 1759-1764.
Voce bibliografica VilaP,1994 capitolo 17
17.VilaP,1994 - Vila P, Hernández MC, López-Fernández MF, Batlle J.
Vila P, Hernandez MC, Lopez-Fernandez MF, Batlle J. Prevalence, follow-up and clinical significance of the anticardiolipin antibodies in normal subjects. Thromb Haemost 1994; 72: 209-213.
Voce bibliografica BlohornA,2002 capitolo 17
17.BlohornA,2002 - Blohorn A, Guegan-Massardier E, Triquenot A, Onnient Y, Tron F, Borg JY, Mihout B.
Blohorn A, Guegan-Massardier E, Triquenot A, Onnient Y, Tron F,Borg JY, Mihout B. Antiphospholipid antibodies in the acute phase ofcerebral ischaemia in young adults: a descriptive study of 139 patients. Cerebrovasc Dis 2002; 13: 156-162.
Voce bibliografica NenciniP,1992 capitolo 17
17.NenciniP,1992 - Nencini P, Baruffi MC, Abbate R, Massai G, Amaducci L, Inzitari D.
Nencini P, Baruffi MC, Abbate R, Massai G, Amaducci L, Inzitari D. Lupus anticoagulant and anticardiolipin antibodies in young adults with cerebral ischemia. Stroke 1992; 23: 189-193.
Voce bibliografica Antiphospholipid,1993 capitolo 17
17.Antiphospholipid,1993 - The Antiphospholipid Antibodies in Stroke Study (APASS) Group.
Anticardiolipin antibodies are an independent risk factor for first ischemic stroke: the Antiphospholipid Antibodies in Stroke Study (APASS) Group. Neurology 1993; 43: 2069-2073.
Voce bibliografica LevineSR,2004 capitolo 17
17.LevineSR,2004 - Levine SR, Brey RL, Tilley BC, Thompson JL, Sacco RL, Sciacca RR, Murphy A, Lu Y, Costigan TM, Rhine C, Levin B, Triplett DA, Mohr JP; APASS Investigators.
Levine SR, Brey RL, Tilley BC, Thompson JL, Sacco RL, Sciacca RR,Murphy A, Lu Y, Costigan TM, Rhine C, Levin B, Triplett DA, Mohr JP, for the APASS Investigators. Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke. JAMA 2004; 291: 576-584.
Voce bibliografica KittnerSJ,1992 capitolo 17
17.KittnerSJ,1992 - Kittner SJ, Gorelick PB.
Kittner SJ, Gorelick PB. Antiphospholipid antibodies and stroke: an epidemiological perspective. Stroke 1992; 23 (suppl): I19-I22.
Voce bibliografica BullerHR,2004 capitolo 17
17.BullerHR,2004 - Büller HR, Agnelli G, Hull RD, Hyers TM, Prins MH, Raskob GE.
Büller HR, Agnelli G, Hull RD, Hyers TM, Prins MH, Raskob GE. Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126 (suppl): 401S-428S.
Voce bibliografica LevineSR,1997 capitolo 17
17.LevineSR,1997 - Levine SR, Salowich-Palm L, Sawaya KL, Perry M, Spencer HJ, Winkler HJ, Alam Z, Carey JL.
Levine SR, Salowich-Palm L, Sawaya KL, Perry M, Spencer HJ, Winkler HJ, Alam Z, Carey JL. IgG anticardiolipin antibody titer >40 GPL and the risk of subsequent thrombo-occlusive events and death: a prospective cohort study. Stroke 1997; 28: 1660-1665.
Voce bibliografica LevineSR,1995 capitolo 17
17.LevineSR,1995 - Levine SR, Brey RL, Sawaya KL, Salowich-Palm L, Kokkinos J, Kostrzema B, Perry M, Havstad S, Carey J.
Levine SR, Brey RL, Sawaya KL, Salowich-Palm L, Kokkinos J,Kostrzema B, Perry M, Havstad S, Carey J. Recurrent stroke and thrombo-occlusive events in the antiphospholipid syndrome. Ann Neurol 1995; 38: 119-124.
Voce bibliografica 100 capitolo 17
17.100 - Levine SR, Brey RL, Joseph CL, Havstad S.
Levine SR, Brey RL, Joseph CL, Havstad S. Risk of recurrent thromboembolic events in patients with focal cerebral ischemia and antiphospholipid antibodies: the Antiphospholipid Antibodies in Stroke Study Group. Stroke 1992; 23 (suppl): I29-I32.
Voce bibliografica RosoveMH,1992 capitolo 17
17.RosoveMH,1992 - Rosove MH, Brewer PM.
Rosove MH, Brewer PMC. Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients. Ann Intern Med 1992; 117: 303-308.